HE News Icon

HEOR News Roundup

Tuesday, Nov. 17, 2020 | Issue 528

email icon Twitter icon Facebook icon LinkedIn Icon Subscribe Contact Advertise HEOR & RWE Marketplace

Sponsored by

ICON Newsletter Banner

The Emergence of ICER in American Pharma

Joe Biden recently suggested that Medicare drug-price negotiations should follow the German model where negotiations between government and drugmakers are informed by a third-party independent analysis.

Read More

Michael L. Ryan of Bristol Myers Squibb Elected Board Chair of National Pharmaceutical Council


[Podcast] How To Best Launch a Therapy For an Ultra-rare Disease?


Value Assessment in the Context of COVID-19


Indication-Based Pricing Gaining Support in UK

 
HEOR news icon
Featured Events

   Webinars

 

Using Patient Preferences to Inform Decision Making

November 20

   
 

HTA and Market Access Implications for Gene Therapies: Learnings for Future Products

December 8

Spotlight

NPC Banner
Conferences Webinars
 
COW
COTA
WOW
University of FL
JOW
Guidehouse
LOW
Pharmerit
 
What we're reading
Syndicated Reports
   
Innovations in Drug Pricing and Reimbursement 2020
 
Healthcare Reimbursement Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026
 
White Papers
   
Interventional Studies
 
Virtual Expanded Access Program Providing Breast Cancer Patients Early Access to Treatment During the COVID-19 Pandemic
 
Careers
 
  Assistant/Associate Director - Oncology Medical Communications (Remote) Divider Analyst/Manager, Evidence Synthesis and Meta-Analyses (Remote) Divider Assistant Professor Health Services Administration Divider Life Sciences Practice Managing Consultant – Market Access HEOR More Jobs  
Post a Job
 
Partner Banner
 
Genesis ResearchPHARUF   SYAPSE
Evidera  HealthCore Evidence PartnersICON
OM1Formulary Decisions  Pharmerit   PRMA
XcendaJeffersonCYTELNPC
 
Become a Partner
HealthEconomics Logo  

Share this newsletter!

 
EMAIL   Twitter   Facebook   LinkedIn